Epilepsy & Seizures
Tonic status epilepticus
Dec. 19, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Axial T2 FLAIR sequence MRI showing bilateral mesiotemporal hyperintensities (arrows) in a patient with a history of type 1 diabetes mellitus limbic encephalitis with underlying active non-small cell lung cancer, treated with durvalumab (PD-1 inhibitor) monthly infusions, stopped when he developed limbic encephalitis. His workup yielded positive GAD65 (serum titer: 533 nmole/L, CSF titer: 11.6 nmole/L). Although the titers are relatively high, GAD65 is rarely considered to be associated with underlying malignancy, and the use of immune checkpoint inhibitor makes irAE of a higher concern. (Contributed by Dr. Lama Abdel Wahed.)